Moderna, Pfizer/BNTX COVID-19 Vaccines Move Into Phase 3, CytoDyn On Watch, GNCA To Report Data On Jul.30
NEW YORK CITY (dpa-AFX) – Today’s Daily Dose brings you news about Moderna moving its COVID-19 vaccine candidate into phase III testing, Pfizer/BioNTech selecting BNT162b2 vaccine candidate for SA… FinanzNachrichten.de:...
